The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Clozapine N-Oxide Administration Produces Behavioral Effects in Long–Evans Rats: Implications for Designing DREADD Experiments
Open accessAbstract
Clozapine N-oxide (CNO) is a ligand for a powerful chemogenetic system that can selectively inhibit or activate neurons; the so-called Designer Receptors Exclusively Activated by Designer Drugs (DREADD) system. This system consists of synthetic G-protein-coupled receptors, which are not believed to be activated by any endogenous ligand, but are activated by the otherwise inert CNO. However, it has previously been shown that the administration of CNO in humans and rats leads to detectable levels of the bioactive compounds clozapine and N-desmethylclozapine (N-Des). As a follow-up, experiments were conducted to investigate the effects of CNO in male Long–Evans rats. It was found that 1 mg/kg CNO reduced the acoustic startle reflex but had no effect on prepulse inhibition (PPI; a measure of sensorimotor gating). CNO (2 and 5 mg/kg) had no effect on the disruption to PPI induced by the NMDA antagonist phencyclidine or the muscarinic antagonist scopolamine. In locomotor studies, CNO alone (at 1, 2, and 5 mg/kg) had no effect on spontaneous locomotion, but 5 mg/kg CNO pretreatment significantly attenuated d-amphetamine-induced hyperlocomotion. In line with the behavioral results, fast-scan cyclic voltammetry found that 5 mg/kg CNO significantly attenuated the d-amphetamine-induced increase in evoked dopamine. However, the effects seen after CNO administration cannot be definitively ascribed to CNO because biologically relevant levels of clozapine and N-Des were found in plasma after CNO injection. Our results show that CNO has multiple dose-dependent effects in vivo and is converted to clozapine and N-Des emphasizing the need for a CNO-only DREADD-free control group when designing DREADD-based experiments.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Armbruster, B. N., Li, X., Pausch, M. H., Herlitze, S., & Roth, B. L. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0700293104 · Cited by 2,046 · cited 1×
“Briefly, this system consists of a family of synthetic GPCRs (based upon the muscarinic M3 and M4 subtypes), which are not believed to be activated by any endogenous ligand but which are potently activated by the otherwise inert molecule CNO (Armbruster et al., 2007).”
BackgroundAlexander, G. M., Rogan, S. C., Abbas, A. I., Armbruster, B. N., Pei, Y., Allen, J. A., Nonneman, R. J., Hartmann, J., Moy, S. S., Nicolelis, M. A., et al. (2009) · Neuron · doi:10.1016/j.neuron.2009.06.014 · Cited by 992
Witten, I. B., Steinberg, E. E., Lee, S. Y., Davidson, T. J., Zalocusky, K. A., Brodsky, M., Yizhar, O., Cho, S. L., Gong, S., Ramakrishnan, C., et al. (2011) · Neuron · doi:10.1016/j.neuron.2011.10.028 · Cited by 680 · cited 1×
“Our experiments were conducted in adult male Long– Evans rats, which, in addition to being a common outbred strain used in many behavioral experiments, are also the genetic background of the pTH:cre and pChAT:cre rats developed by Witten et al. (2011).”
Realistic expectations of prepulse inhibition in translational models for schizophrenia research
Swerdlow, N. R., Weber, M., Qu, Y., Light, G. A., & Braff, D. L. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1072-4 · Cited by 529
Ferguson, S. M., Eskenazi, D., Ishikawa, M., Wanat, M. J., Phillips, P. E. M., Dong, Y., Roth, B. L., & Neumaier, J. F. (2011) · Nature Neuroscience · doi:10.1038/nn.2703 · Cited by 418
Impaired Respiratory and Body Temperature Control Upon Acute Serotonergic Neuron Inhibition
Ray, R. S., Corcoran, A. E., Brust, R. D., Kim, J. C., Richerson, G. B., Nattie, E., & Dymecki, S. M. (2011) · Science · doi:10.1126/science.1205295 · Cited by 372
Grace, P. M., Strand, K. A., Galer, E. L., Urban, D. J., Wang, X., Baratta, M. V., Fabisiak, T. J., Anderson, N. D., Cheng, K., Greene, L. I., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1602070113 · Cited by 367
A chemical-genetic approach to study G protein regulation of β cell function in vivo
Guettier, J.-M., Gautam, D., Scarselli, M., de Azua, I. R., Li, J. H., Rosemond, E., Ma, X., Gonzalez, F. J., Armbruster, B. N., Lu, H., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0906593106 · Cited by 344
Yorgason, J. T., España, R. A., & Jones, S. R. (2011) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2011.03.001 · Cited by 315
Self-citationSur, C., Mallorga, P. J., Wittmann, M., Jacobson, M. A., Pascarella, D., Williams, J. B., Brandish, P. E., Pettibone, D. J., Scolnick, E. M., & Conn, P. J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1835612100 · Cited by 294
Metabolism and bioactivation of clozapine by human liver in vitro.
Pirmohamed, M., Williams, D., Madden, S., Templeton, E., & Park, B. K. (1995) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)24566-9 · Cited by 268
Pharmacokinetics and Pharmacodynamics of Clozapine
Jann, M. W., Grimsley, S. R., Gray, E. C., & Chang, W.-H. (1993) · Clinical Pharmacokinetics · doi:10.2165/00003088-199324020-00005 · Cited by 257
España, R. A., Oleson, E. B., Locke, J. L., Brookshire, B. R., Roberts, D. C. S., & Jones, S. R. (2010) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2009.07065.x · Cited by 250
Self-citationControlling signaling with a specifically designed G i -coupled receptor
Coward, P., Wada, H. G., Falk, M. S., Chan, S. D. H., Meng, F., Akil, H., & Conklin, B. R. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.1.352 · Cited by 247
General Pharmacology of Clozapine
Coward, D. M. (1992) · British Journal of Psychiatry · doi:10.1192/s0007125000296840 · Cited by 239
Tissue Concentrations of Clozapine and its Metabolites in the Rat
Baldessarini, R. J., Centorrino, F., Flood, J. G., Volpicelli, S. A., Huston-Lyons, D., & Cohen, B. M. (1993) · Neuropsychopharmacology · doi:10.1038/npp.1993.50 · Cited by 233
Schotte, A., Janssen, P. F. M., Megens, A. A. H. P., & Leysen, J. E. (1993) · Brain Research · doi:10.1016/0006-8993(93)91535-z · Cited by 227
Gq-DREADD Selectively Initiates Glial Glutamate Release and Inhibits Cue-induced Cocaine Seeking
Scofield, M. D., Boger, H. A., Smith, R. J., Li, H., Haydon, P. G., & Kalivas, P. W. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.02.016 · Cited by 197
Keith, V. A., Mansbach, R. S., & Geyer, M. A. (1991) · Biological Psychiatry · doi:10.1016/0006-3223(91)90025-h · Cited by 186
Redfern, C. H., Coward, P., Degtyarev, M. Y., Lee, E. K., Kwa, A. T., Hennighausen, L., Bujard, H., Fishman, G. I., & Conklin, B. R. (1999) · Nature Biotechnology · doi:10.1038/6165 · Cited by 178
Chen, X., Choo, H., Huang, X., Yang, X., Stone, O. J., Roth, B. L., & Jin, J. J. (2015) · ACS Chemical Neuroscience · doi:10.1021/cn500325v · Cited by 173
España, R. A., Melchior, J. R., Roberts, D. C. S., & Jones, S. R. (2011) · Psychopharmacology · doi:10.1007/s00213-010-2048-8 · Cited by 169
Self-citationChemical–genetic attenuation of focal neocortical seizures
Kätzel, D., Nicholson, E., Schorge, S., Walker, M. C., & Kullmann, D. M. (2014) · Nature Communications · doi:10.1038/ncomms4847 · Cited by 166
Zhu, H., Pleil, K. E., Urban, D. J., Moy, S. S., Kash, T. L., & Roth, B. L. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.35 · Cited by 162
Seroquel restores sensorimotor gating in phencyclidine-treated rats.
Swerdlow, N. R., Bakshi, V. P., & Geyer, M. A. (1996) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)21289-7 · Cited by 154
A Gαs DREADD Mouse for Selective Modulation of cAMP Production in Striatopallidal Neurons
Farrell, M. S., Pei, Y., Wan, Y., Yadav, P. N., Daigle, T. L., Urban, D. J., Lee, H.-M., Sciaky, N., Simmons, A., Nonneman, R. J., et al. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.251 · Cited by 150
Agulhon, C., Boyt, K. M., Xie, A. X., Friocourt, F., Roth, B. L., & McCarthy, K. D. (2013) · The Journal of Physiology · doi:10.1113/jphysiol.2013.261289 · Cited by 147
Bull, C., Freitas, K. C., Zou, S., Poland, R. S., Syed, W. A., Urban, D. J., Minter, S. C., Shelton, K. L., Hauser, K. F., Negus, S. S., et al. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.135 · Cited by 145
Chemogenetic Silencing of Neurons in Retrosplenial Cortex Disrupts Sensory Preconditioning
Robinson, S., Todd, T. P., Pasternak, A. R., Luikart, B. W., Skelton, P. D., Urban, D. J., & Bucci, D. J. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.1349-14.2014 · Cited by 131
Davies, M. A., Compton-Toth, B. A., Hufeisen, S. J., Meltzer, H. Y., & Roth, B. L. (2004) · Psychopharmacology · doi:10.1007/s00213-004-2017-1 · Cited by 128
Boender, A. J., de Jong, J. W., Boekhoudt, L., Luijendijk, M. C. M., Plasse, G., & Adan, R. A. H. (2014) · PLoS ONE · doi:10.1371/journal.pone.0095392 · Cited by 126
Remote control of induced dopaminergic neurons in parkinsonian rats
Dell’Anno, M. T., Caiazzo, M., Leo, D., Dvoretskova, E., Medrihan, L., Colasante, G., Giannelli, S. G., Theka, I., Russo, G., Mus, L., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci74664 · Cited by 126
Qiu, M. H., Chen, M. C., Fuller, P. M., & Lu, J. (2016) · Current Biology · doi:10.1016/j.cub.2016.07.054 · Cited by 121
Direct-Pathway Striatal Neurons Regulate the Retention of Decision-Making Strategies
Ferguson, S. M., Phillips, P. E. M., Roth, B. L., Wess, J., & Neumaier, J. F. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.4783-12.2013 · Cited by 97
Gompf, H. S., Budygin, E. A., Fuller, P. M., & Bass, C. E. (2015) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2015.00152 · Cited by 92
Reversible metabolism of clozapine and clozapine N-oxide in schizophrenic patients
Chang, W., Lin, S., Lane, H., Wei, F., Hu, W.-H., Lam, Y. F., & Jann, M. W. (1998) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(98)00035-9 · Cited by 92
Rapid formation of clozapine in guinea-pigs and man following clozapine-N-oxide administration.
Jann, M. W., Lam, Y. W. F., & Chang, W. H. (1994) · PubMed · Cited by 90
Michaelides, M., Anderson, S. A. R., Ananth, M. R., Smirnov, D. S., Thanos, P. K., Neumaier, J. F., Wang, G., Volkow, N. D., & Hurd, Y. L. (2013) · Journal of Clinical Investigation · doi:10.1172/jci72117 · Cited by 88
Chemogenetic manipulation of ventral pallidal neurons impairs acquisition of sign‐tracking in rats
Chang, S. E., Todd, T. P., Bucci, D. J., & Smith, K. S. (2015) · European Journal of Neuroscience · doi:10.1111/ejn.13103 · Cited by 76
Behavioral and Physiological Effects of a Novel Kappa-Opioid Receptor-Based DREADD in Rats
Marchant, N. J., Ramsey, L. A., Bossert, J. M., Harvey, B. K., Hope, B. T., Kaganovsky, K., Adhikary, S., Prisinzano, T. E., Vardy, E., Roth, B. L., et al. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.149 · Cited by 75
Pienaar, I. S., Gartside, S. E., Sharma, P., Paola, V. D., Gretenkord, S., Withers, D. J., Elson, J. L., & Dexter, D. T. (2015) · Molecular Neurodegeneration · doi:10.1186/s13024-015-0044-5 · Cited by 67
Pharmacogenetic activation of midbrain dopaminergic neurons induces hyperactivity
Wang, S., Tan, Y., Zhang, J.-E., & Luo, M. (2013) · Neuroscience Bulletin · doi:10.1007/s12264-013-1327-x · Cited by 66
Pharmacogenetic Excitation of Dorsomedial Prefrontal Cortex Restores Fear Prediction Error
Yau, J. O.-Y., & McNally, G. P. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.3777-14.2015 · Cited by 65
Chemogenetic silencing of the midline and intralaminar thalamus blocks amygdala-kindled seizures
Wicker, E., & Forcelli, P. A. (2016) · Experimental Neurology · doi:10.1016/j.expneurol.2016.07.003 · Cited by 59
Impaired periamygdaloid-cortex prodynorphin is characteristic of opiate addiction and depression
Anderson, S. A. R., Michaelides, M., Zarnegar, P., Ren, Y., Fagergren, P., Thanos, P. K., Wang, G., Bannon, M. J., Neumaier, J. F., Keller, É., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci70395 · Cited by 55
Nucleus incertus promotes cortical desynchronization and behavioral arousal
Ma, S., Allocca, G., Ong-Pålsson, E., Singleton, C. E., Hawkes, D. J., McDougall, S. J., Williams, S. J., Bathgate, R. A. D., & Gundlach, A. L. (2016) · Brain Structure and Function · doi:10.1007/s00429-016-1230-0 · Cited by 54
Evaluation of N-Desmethylclozapine as a Potential Antipsychotic—Preclinical Studies
Natesan, S., Reckless, G. E., Barlow, K. B. L., Nóbrega, J. N., & Kapur, S. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301279 · Cited by 53
Polypharmacology in Drug Discovery
Peters, J. (2012) · Wiley eBooks · doi:10.1002/9781118098141 · Cited by 49
Insular neural system controls decision-making in healthy and methamphetamine-treated rats
Mizoguchi, H., Katahira, K., Inutsuka, A., Fukumoto, K., Nakamura, A., Wang, T., Nagai, T., Sato, J., Sawada, M., Ohira, H., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1418014112 · Cited by 49 · cited 4×
“Of the 22 articles that we found that used systemic administration of CNO in rats (Ferguson et al., 2011, 2013; Anderson et al., 2013; Michaelides et al., 2013; Boender et al., 2014; Bull et al., 2014; Dell’Anno et al., 2014; Kätzel et al., 2014; Robinson et al., 2014; Chang et al., 2015; Gompf et al., 2015; Mizoguchi…”
BackgroundMethodInfluentialFurther evidence for clozapine as a dopamine D1 receptor agonist
Salmi, P., & Ahlénius, S. (1996) · European Journal of Pharmacology · doi:10.1016/0014-2999(96)00181-1 · Cited by 47
Lin, G., McKay, G., & Midha, K. K. (1996) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/0731-7085(96)01738-4 · Cited by 38
Disrupted Prediction Error Links Excessive Amygdala Activation to Excessive Fear
Sengupta, A., Winters, B. L., Bagley, E. E., & McNally, G. P. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.3670-15.2016 · Cited by 38
Lin, G., McKay, G., Hubbard, J. W., & Midha, K. K. (1994) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600831010 · Cited by 34
Microdialysis Evaluation of Clozapine and N-Desmethylclozapine Pharmacokinetics in Rat Brain
Cremers, T. I. F. H., Flik, G., Hofland, C. M., & Stratford, R. E. (2012) · Drug Metabolism and Disposition · doi:10.1124/dmd.112.045682 · Cited by 29
Huang, X., Tan, Y. Y., Huang, X., & Wang, Q. (2007) · Neuroscience Research · doi:10.1016/j.neures.2007.08.001 · Cited by 28
N-desmethylclozapine (NDMC) is an antagonist at the human native muscarinic M1 receptor
Thomas, D. R., Dada, A., Jones, G. A., Deisz, R. A., Gigout, S., Langmead, C. J., Werry, T. D., Hendry, N., Hagan, J. J., Davies, C. H., et al. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.02.017 · Cited by 25
Conti, L. H., Costill, J. E., Flynn, S. P., & Tayler, J. E. (2005) · Behavioral Neuroscience · doi:10.1037/0735-7044.119.4.1052 · Cited by 25
Clozapine and PD149163 elevate prepulse inhibition in Brown Norway rats.
Feifel, D., Shilling, P. D., & Melendez, G. (2011) · Behavioral Neuroscience · doi:10.1037/a0022691 · Cited by 21
Effects of clozapine metabolites and chronic clozapine treatment on rat brain GABAA receptors
Wong, G., Kuoppamäki, M., Hietala, J. A., Lüddens, H., Syvälahti, E. K. G., & Korpi, E. R. (1996) · European Journal of Pharmacology · doi:10.1016/s0014-2999(96)00671-1 · Cited by 18
Cited by
The oxytocin receptor: from intracellular signaling to behavior
Jurek, B., & Neumann, I. D. (2018) · Physiological Reviews · doi:10.1152/physrev.00031.2017 · Cited by 999
Chemogenetics revealed: DREADD occupancy and activation via converted clozapine
Gomez, J. L., Bonaventura, J., Lesniak, W., Mathews, W. B., Sysa-Shah, P., Rodriguez, L. A., Ellis, R. J., Richie, C. T., Harvey, B. K., Dannals, R. F., et al. (2017) · Science · doi:10.1126/science.aan2475 · Cited by 980
Manvich, D. F., Webster, K. A., Foster, S. L., Farrell, M. S., Ritchie, J. C., Porter, J. H., & Weinshenker, D. (2018) · Scientific Reports · doi:10.1038/s41598-018-22116-z · Cited by 367
Pharmacogenetic stimulation of neuronal activity increases myelination in an axon-specific manner
Mitew, S., Gobius, I., Fenlon, L. R., McDougall, S. J., Hawkes, D., Xing, Y. L., Bujalka, H., Gundlach, A. L., Richards, L. J., Kilpatrick, T. J., et al. (2018) · Nature Communications · doi:10.1038/s41467-017-02719-2 · Cited by 343
Silencing Neurons: Tools, Applications, and Experimental Constraints
Wiegert, J. S., Mahn, M., Prigge, M., Printz, Y., & Yizhar, O. (2017) · Neuron · doi:10.1016/j.neuron.2017.06.050 · Cited by 312
Metadata
- Authors
- MacLaren, D. A. A., Browne, R. W., Shaw, J. K., Krishnan Radhakrishnan, S., Khare, P., España, R. A., & Clark, S. D.
- Venue
- eneuro
- Publisher
- Society for Neuroscience
- Published
- 2016-09
- Volume
- 3
- Issue
- 5
- Pages
- ENEURO.0219-16.2016
- ISSN
- 2373-2822 (ISSN-L)
- OpenAlex
- W2530703593
- Cited by
- 331
- References
- 59
- FWCI
- 21.50
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.